update on tirzepatide lawsuit Compounding pharmacies can resume making as FDA reconsiders shortage 🚨BREAKING: Compound Tirzepatide Lawsuit Update!!!

If youve hit a plateau, consider reviewing your calorie intake, increasing daily activity, incorporating strength training, improving sleep quality, managing stress, and ensuring youre getting enough protein

The objective of this meta-analysis is to assess the safety concerns of tirzepatide, specifically regarding the potential risk of pancreatitis and gallbladder or biliary disease, in individuals with T2D and obesity

Safety is not established

Headaches occur in roughly 10 to 15 percent of users, typically mild and transient

great product Use to have a hard time getting the weight off but this has helped SO MUCH

These data reflect exposure of 718 patients to MOUNJARO and a mean duration of exposure to MOUNJARO of 36.6 weeks